EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diabetes, Obesity, and Endometrial Cancer: A Review

Olivia Hooks, Vama Jhumkhawala iD, Kristen Sibson, Abbigail Shrontz, Syamala Soumya Krishnan, Sarfraz Ahmad iD

Current Oncology · 29.11.2025 · 32 (12) · 672

DOI: 10.3390/curroncol32120672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 29.11.2025. Verfasst von Olivia Hooks und 5 weiteren Autor:innen. Beteiligte Einrichtung: Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Obesity, Diabetes Mellitus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial cancer is the fourth most diagnosed cancer in U.S. women. Diabetes and obesity are established independent risk factors for EC, but their combined effect is less defined. This review investigates the literature on these comorbidities as risk factors and modifiers of EC. Multiple cohort and case–control investigations have shown an increased relative risk (RR) and odds ratio (OR) when diabetes and obesity coexist. In one prospective cohort, the RR of EC in diabetic women was 1.94 [95% CI, 1.23–3.08], but increased to 6.39 [95% CI, 3.28–12.06] with obesity; with low physical activity added, RR rose to 9.61 [95% CI, 4.66–19.83]. Case–control studies similarly show an OR of 1.4 [95% CI, 0.9–2.4] for diabetes alone, vs. 5.1 [95% CI, 3.0–8.7] with BMI > 30 and diabetes. Mechanistically, both conditions promote a pro-cancerous microenvironment through metabolic and inflammatory pathways. They also worsen treatment outcomes, with greater surgical complications, thromboembolic events (p < 0.01), prolonged hospitalizations 6.2 days versus 4.5 days (p < 0.03), and poorer survival with an elevated cancer-specific mortality (HR = 2.65, 95% CI 1.60–4.40). These findings underscore the urgent need for targeted interventions and translational research on how these comorbidities impact the pathophysiologic processes of EC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsObesityDiabetes MellitusHumansFemaleRisk Factors

Stichwörter der Autor:innen

comorbid risk factorsdiabetesendometrial cancermetabolismobesityuterine cancer

Autor:innen und Institutionen

  • Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.
  • Department of Medicine, Division of Pulmonary and Critical Care, Downstate Health Sciences University, State University of New York, Brooklyn, NY 11203, USA.
  • AdventHealth Cancer Institute, Gynecologic Oncology Program, Orlando, FL 32804, USA.

ORCID-Profile: Vama Jhumkhawala, Sarfraz Ahmad

Zitieren

APA

Hooks, O., Jhumkhawala, V., Sibson, K., Shrontz, A., Krishnan, S. S., & Ahmad, S. (2025). Diabetes, Obesity, and Endometrial Cancer: A Review. Current Oncology, 32(12), 672. https://doi.org/10.3390/curroncol32120672

Vancouver

Hooks O, Jhumkhawala V, Sibson K, Shrontz A, Krishnan SS, Ahmad S. Diabetes, Obesity, and Endometrial Cancer: A Review. Current Oncology. 2025;32(12):672. doi:10.3390/curroncol32120672

BibTeX
@article{Hooks2025,
  author = {Hooks, Olivia and Jhumkhawala, Vama and Sibson, Kristen and Shrontz, Abbigail and Krishnan, Syamala Soumya and Ahmad, Sarfraz},
  title = {Diabetes, Obesity, and Endometrial Cancer: A Review},
  journal = {Current Oncology},
  year = {2025},
  volume = {32},
  number = {12},
  pages = {672},
  doi = {10.3390/curroncol32120672}
}
Kostenlos starten →